SCHEMBL5385079

SCHEMBL5385079

NC1C[C@H](N)CN(c2nc(NC3CCNC3)nc(N3CC(N)C[C@H](N)C3)n2)C1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IDH2 P48735 1/20 0.37
CTSL P07711 1/20 0.36
CTSB P07858 1/20 0.36
CTSS P25774 1/20 0.36
CTSK P43235 1/20 0.36
MKNK1 Q9BUB5 1/20 0.35
MKNK2 Q9HBH9 1/20 0.35
PIK3CB P42338 1/20 0.35
ROCK1 Q13464 2/20 0.34
CLK1 P49759 2/20 0.33
CLK2 P49760 2/20 0.33
CLK4 Q9HAZ1 2/20 0.33
HRH4 Q9H3N8 2/20 0.33
PLK4 O00444 1/20 0.33
PAK4 O96013 1/20 0.33
BPTF Q12830 2/20 0.32
CCNT1 O60563 2/20 0.32
CDK9 P50750 2/20 0.32
ADORA2A P29274 1/20 0.32
HTT P42858 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5385088 1.00 IDH2 (0.37) IDH2CTSLCTSBCTSSCTSK
SCHEMBL5391787 0.92 CTSL (0.40) IDH2CTSLCTSBCTSSCTSK
SCHEMBL5430492 0.92 CTSL (0.43) CTSLCTSBCTSSCTSKMKNK1
SCHEMBL14533282 0.85 IDH2 (0.39) IDH2CTSLCTSBCTSSCTSK
SCHEMBL5450826 0.85 IDH2 (0.42) IDH2CTSLCTSBCTSSCTSK
SCHEMBL14503102 0.81 PDE4A (0.41) CTSLCTSBCTSSCTSKPIK3CB
SCHEMBL5455697 0.80 HTT (0.49) CTSLCTSBCTSSCTSKROCK1
SCHEMBL5458339 0.80 HTT (0.49) CTSLCTSBCTSSCTSKROCK1
SCHEMBL5382801 0.80 HTT (0.49) CTSLCTSBCTSSCTSKROCK1
SCHEMBL5380632 0.77 KDM1A (0.36) HRH4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7223759-B2 Antibacterial 3,5-diaminopiperidine-substituted aromatic and heteroaromatic compounds ANADYS PHARMACEUTICALS, INC. (US) 2007-05-29 US disclosed
US-20050239827-A1 Antibacterial 3,5-diaminopiperidine-substituted aromatic and heteroaromatic compouds ANADYS PHARMACEUTICALS, INC. 2005-10-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050239827-A1 Antibacterial 3,5-diaminopiperidine-substituted aromatic and heteroaromatic compouds AMPD3, AAAS, PEPD IDH2 3493/4885CTSL 507/4885CTSB 455/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.